ArticleCureus2025
Chronic Diarrhea and Alcoholism: Unravelling the Connection to Pellagra.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mirtazapine for the treatment of irritable bowel syndrome: A systematic review.World journal of methodology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pellagra is a deadly systemic disease caused by niacin deficiency or a disorder of its metabolism. It typically presents as a classic triad of diarrhea, dermatitis, and dementia. It is increasingly seen among high-risk populations such as those with poor socioeconomic status, immunocompromised states, chronic alcoholism, malabsorption disorders, and populations heavily reliant on a corn-based diet. We report a case of a 39-year-old man presenting with watery diarrhea and hyperpigmentation over the sun-exposed areas of the face and arms, with a history of alcohol use disorder. Differential diagnoses were excluded. Niacinamide supplements and lifestyle modifications were recommended, resulting in the resolution of the symptoms. This case report emphasizes the need for a high index of suspicion when diagnosing pellagra in vulnerable populations to ensure prompt treatment and recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.